Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,527,706
+$218,199 QoQ
Shares Held
6,071
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#2,159
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Management Professionals, Inc. holds $5,803,019 across 15 Drug Manufacturers - General names. ABBV ranks #1 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
6,071 | $1,527,706 | |
| 2 | LLY |
ELI LILLY & Co
|
933 | $1,119,068 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
7,239 | $914,575 | |
| 4 | JNJ |
Johnson & Johnson
|
3,299 | $837,847 | |
| 5 | AMGN |
Amgen Inc
|
1,624 | $588,082 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,783 | $486,115 | |
| 7 | PFE |
Pfizer Inc
|
4,666 | $112,357 | |
| 8 | NVS |
Novartis AG
|
562 | $88,076 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,527,706 | 6,071 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,309,507 | 6,021 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,268,347 | 5,551 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,288,751 | 5,566 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,031,119 | 5,555 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,276,395 | 6,092 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $980,193 | 5,516 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,002,803 | 5,078 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $856,056 | 4,991 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $773,742 | 4,249 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $794,066 | 5,124 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $706,097 | 4,737 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $573,815 | 4,259 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $581,859 | 3,651 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $536,706 | 3,321 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $412,158 | 3,071 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $610,648 | 3,987 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $728,522 | 4,494 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $578,158 | 4,270 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $459,634 | 4,261 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $446,955 | 3,968 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $405,392 | 3,746 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $354,880 | 3,312 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $276,521 | 3,157 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $302,099 | 3,077 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $52,113 | 684 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||